Orion Group Holdings, Inc. (ORN) Stock Price & Analysis
Orion Group Holdings, Inc. (ORN) closed at USD 8.41 on Thursday, October 22, 2026, down 2.89% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 8.66; the Oct 22, 2026 session ranged USD 8.29–8.6 on volume of 513,397 shares. Market capitalization is $340.57M, with a 52-week range of USD 8.15–17.4 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ORN.md
Key facts (ORN)
- 1 of 80 tracked superinvestors hold ORN (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.83 on a 1–5 scale) (6 analysts), mean target USD 14.98 (range 14–15.9).
- Total return with dividends: 1Y -2.2% vs S&P 500 +14.9%; 5Y +80.1% vs S&P 500 +80.3%.
- Next earnings: 2026-10-27, EPS estimate USD 0.09, revenue estimate $246M.
Superinvestors (SEC 13F-HR, Q2 2026) (ORN)
1 of 80 tracked investors hold ORN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Tweedy Browne | 0.05% | $600K | Added +48.1% |
Analysts (ORN)
Consensus Buy (mean 1.83 on a 1–5 scale), 6 analysts; mean target USD 14.98 (low 14, high 15.9).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | JP Morgan | Target lowered | Overweight | $16 → $14 |
| 2026-07-07 | Oppenheimer | Initiated | Outperform | $20 |
Total return (dividends reinvested) (ORN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -2.2% | +80.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -2.2% | +12.4% |
| Volatility (annualized) | 60.7% | 63.4% |
| Max drawdown | -51.3% (Jun 2026→Sep 2026) | -56.2% (Nov 2021→Feb 2022) |
Companies that name ORN in their SEC reports
| Relationship to ORN | Company | Filing | Sentence |
|---|---|---|---|
| partner | Pelthos Therapeutics Inc. (PTHS) | 10-K Mar 19, 2026 | “In February 2025, LNHC entered into a non-exclusive Contract Management Agreement with Orion to manufacture and assemble various components related to the ZELSUVMI commercial drug product, including the final fill/finish process and product packaging.” |
| customer | TENAX THERAPEUTICS, INC. (TENX) | 10-K Mar 10, 2026 | “The amendment also (i) increased the Company's obligations to make certain non-refundable commercialization milestone payments to Orion, aggregating to up to $45.0 million, contingent upon achievement of certain cumulative worldwide sales of the product by the Company, and (ii) reduced the maximum price per capsule payable by the Company to Orion, under a yet-to-be-negotiated supply agreement, for the commercial s…” |
| partner | Amneal Pharmaceuticals, Inc. (AMRX) | 10-K Feb 27, 2026 | “Orion Corporation License Agreement” |
ORN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.09 | $0.15 | -37.6% | $245.6M | 6 |
| Next quarter (ends Dec 2026) | $0.09 | $0.14 | -38.3% | $245.8M | 6 |
| Current fiscal year (ends Dec 2026) | $0.25 | $0.40 | -36.0% | $929.5M | 6 |
| Next fiscal year (ends Dec 2027) | $0.44 | $0.66 | -33.2% | $1.00B | 6 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 8.41 |
|---|---|
| Change | ▼ 2.89% (down) |
| Previous Close | USD 8.66 |
| Open | USD 8.56 |
| Day Range | USD 8.29 – 8.6 |
| 52-Week Range | USD 8.15 – 17.4 |
| Volume | 513,397 shares |
| Market Cap | $340.57M |
| Exchange | NYQ |
Technical Analysis (ORN)
Nexqual's technical model rates ORN "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.45 (neutral) |
| vs SMA50 | Below (USD 9.09) |
| MACD | -0.17 (negative) |
Analyst Ratings (ORN)
Wall Street analysts rate ORN "Buy" based on 6 analysts, with a mean price target of USD 14.98 (range USD 14–15.9), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 14.98 |
| High Target | USD 15.9 |
| Low Target | USD 14 |
| Buy / Hold / Sell | 6 / 0 / 0 |
Earnings (ORN)
| Next Earnings Date | 2026-10-27 |
|---|---|
| EPS Estimate | USD 0.09 |
| Revenue Estimate | $245.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.02 vs est 0.06 ▼ miss |
| 2026-03-31 | USD 0.05 vs est 0 ▲ beat |
| 2025-12-31 | USD 0.08 vs est 0.05 ▲ beat |
| 2025-09-30 | USD 0.09 vs est 0.06 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (ORN)
| Total Revenue | $896.50M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +8.10% |
| Gross Margin | +11.78% |
| Operating Margin | -0.66% |
| Profit Margin | +0.40% |
| ROE | +2.27% |
| Debt / Equity | 0.99 |
| Current Ratio | 1.52 |
| Total Cash | $2.53M |
| Total Debt | $162.70M |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (ORN)
Nexqual rates Orion Group Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Critical — Gross margin 12%, operating -1% (last 12 months) |
| Balance Sheet | Mixed — $3M cash vs $163M debt |
| Cash Flow | Solid — Operating cash flow $24M (TTM) |
| Efficiency | Weak — ROE 2%, ROA 1.1% |
Ownership (ORN)
| Insider Ownership | +5.80% |
|---|---|
| Institutional Ownership | +88.35% |
| Shares Outstanding | 40.50M |
| Float | 38.15M |
| Short % of Float | +7.37% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (ORN)
Orion Group Holdings, Inc. is led by Travis J. Boone, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| CEO, President & Director | Travis J. Boone |
|---|---|
| Director of Investor Relations | Margaret Boyce |
| Vice President of Human Resources | Shallee E. Biondo SPHR |
| Executive Vice President of Orion Marine Group | Scott H. Cromack |
| Executive Vice President of TAS Concrete Construction, LLC | Ardell C. Allred |
Major Backers & Investors (ORN)
Notable institutional backers of Orion Group Holdings, Inc. include Brandes Investment Partners L.P., Wasatch Advisors LP, Royce & Associates LP, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Brandes Investment Partners L.P. | 12.14% |
| Wasatch Advisors LP | 5.34% |
| Royce & Associates LP | 3.95% |
| WASATCH FUNDS TRUST-Wasatch Micro Cap Fund | 3.83% |
| Datum One Series Trust-BRANDES SMALL CAP VALUE FUND | 3.29% |
| Gendell, Jeffrey L. | 2.73% |
| Next Century Growth Investors LLC | 2.44% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.43% |
| Vanguard Group | 4.19% |
| Dimensional Fund Advisors | 3.65% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TPC | Tutor Perini Corporation | USD 76.88 | ▼ 4.09% |
| AGX | Argan, Inc. | USD 330.3 | ▼ 4.5% |
| ROAD | Construction Partners, Inc. | USD 83.93 | ▼ 1.19% |
| GVA | Granite Construction Incorporat | USD 107.45 | ▼ 2.08% |
| ECG | Everus Construction Group, Inc. | USD 97.05 | ▼ 8.44% |
| KBR | KBR, Inc. | USD 39.53 | ▲ 5.95% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt